Controlled administration of chemodenervating pharmaceuticals
US5298019A · kind A · utility
43Cited by
13References
3Claims
0Family size
Assignee
Inventor
Key dates
| Filing date | Jan 13, 1993 |
| Grant date | Mar 29, 1994 |
| Priority date | — |
| Expiry date | Jan 13, 2013 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
This invention relates to a method for controlled administration of chemodernervating agents such as botulinum toxin-derived pharmaceutical, useful in attenuating neural stimulation and spasmodic activity of muscle. The method involves administration of novel dosage forms based upon the standardization of denervating pharmaceuticals. The invention also relates to novel methods of administrating chemodernervating agents in a controlled and reproducible manner so as to confine their effects to a given region of muscle mass while minimizing in adjacent muscle tissue.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.